Your browser doesn't support javascript.
loading
Ovarian cancer stem cells promote tumour immune privilege and invasion via CCL5 and regulatory T cells.
You, Y; Li, Y; Li, M; Lei, M; Wu, M; Qu, Y; Yuan, Y; Chen, T; Jiang, H.
Afiliación
  • You Y; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
  • Li Y; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
  • Li M; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
  • Lei M; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
  • Wu M; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
  • Qu Y; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
  • Yuan Y; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
  • Chen T; Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China.
  • Jiang H; Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China.
Clin Exp Immunol ; 191(1): 60-73, 2018 01.
Article en En | MEDLINE | ID: mdl-28868628
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Células Madre Neoplásicas / Linfocitos T Reguladores / Quimiocina CCL5 / Privilegio Inmunológico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Exp Immunol Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Células Madre Neoplásicas / Linfocitos T Reguladores / Quimiocina CCL5 / Privilegio Inmunológico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Clin Exp Immunol Año: 2018 Tipo del documento: Article País de afiliación: China